Dr Megan Penno
Grant-Funded Researcher (C)
School of Medicine
College of Health
Dr Megan Penno (BSc Hons PhD, University of Melbourne) is the Chief Operating Officer for the Environmental Determinants of Islet Autoimmunity (ENDIA) study and Grant-Funded Research at Adelaide University, Australia. ENDIA is the first study in the world to explore how environmental exposures from pregnancy through early life may contribute to, or protect against, the development of childhood type 1 diabetes.
Dr Megan Penno has provided leadership for the ENDIA study since its establishment in 2012 and has played a pivotal role in the development of Australia's largest pregnancy–birth cohort investigating type 1 diabetes. She led the design of ENDIA's sample and data collection frameworks, authored the study protocol, and has contributed to the strategic growth of the cohort and its associated biobank and data resources. Dr Penno has secured and contributed to successful national and international funding applications exceeding AU$32 million over the past five years and provides leadership in research governance, infrastructure development, and multidisciplinary collaborations. Her research focuses on biomarker discovery and the translation of omics approaches to disease prediction and risk stratification.
For more information about the ENDIA study please visit our website at http://www.endia.org.au
| Date | Position | Institution name |
|---|---|---|
| 2019 - ongoing | Grant Funded Researcher | University of Adelaide |
| 2015 - 2018 | Academic Research Clinical Coordinator | University of Adelaide |
| 2012 - 2014 | Senior Clinical Research Coordinator | University of Adelaide |
| 2007 - 2012 | Post-doctoral fellow | University of Adelaide |
| 2006 - 2006 | Grant Funded Scientist | Hanson Institute |
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2022 | Research Award | Faculty of Health and Medical Sciences Executive Dean's Award for Research Excellence (mid-career) | The University of Adelaide | Australia | - |
| 2020 | Award | IDS 17th Congress High-Scoring Abstracts Award | Immunology of Diabetes Society | China | - |
| 2018 | Award | CUDOS 2018 Conference poster prize | Sidra Medicine | Qatar | - |
| 2018 | Nomination | JDRF Australia & Macquarie Group Foundation Future Leader Program | JDRF Australia | Australia | - |
| 2014 | Award | Robinson Research Institute Travel Award | University of Adelaide, Robinson Research Institute | Australia | $1,100 |
| 2011 | Award | Research Career Development Network (RCDN) Workshop Award | University of Adelaide, School of Molecular and Biomedical Sciences | Australia | $2,000 |
| 2008 | Award | Overseas Conference Scheme Travel Award | University of Adelaide, Faculty of Science | Australia | $2,000 |
| 2004 | Award | American Society for Biochemistry and Molecular Biology Graduate Travel Award | The American Society for Biochemistry and Molecular Biology | United States | US$1,000 |
| 2004 | Award | Dawson Bursary | The University of Melbourne | Australia | $6,000 |
| 2004 | Award | School of Botany Travel Scholarship | The University of Melbourne, School of Botany | Australia | - |
| 2003 | Scholarship | Sir John and Lady Higgins Research Scholarship | The University of Melbourne | Australia | $70,000 |
| Language | Competency |
|---|---|
| English | Can read, write, speak, understand spoken and peer review |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2003 - 2007 | University of Melbourne | Australia | PhD |
| 1999 - 2002 | University of Melbourne | Australia | BSc (Honours) |
| Year | Citation |
|---|---|
| 2007 | Allen, J. G., Retallick, M., Kowalski, M., Colegate, S. M., Speijers, E. J., Doran, T., . . . others. (2007). A study of the bioequivalence of corynetoxins and tunicamycins: the effect of these toxins on the viability and morphology of rat hepatocytes in tissue culture.. In Unknown Book (pp. 504-510). CABI. |
| 2007 | Retallick, M. A. S., Colegate, S. M., Michalski, W. P., Panter, K. E., Wierenga, T. L., Pfister, J. A., & others. (2007). A toxicoproteomic approach to understanding annual ryegrass toxicity.. In Unknown Book (pp. 230-234). CABI. |
| Year | Citation |
|---|---|
| 2026 | Zaitouny, A., Krishnan, A., Chee, J., Smith, G., Tully, A., Penno, M., . . . Haynes, A. (2026). INTEGRATING SYMBOLIC STATISTICAL AND MACHINE LEARNING TO ANALYSE CGM DATA FROM YOUNG CHILDREN WITH PRE-SYMPTOMATIC TYPE 1 DIABETES. In DIABETES TECHNOLOGY & THERAPEUTICS Vol. 28 (pp. 64S-65S). SAGE PUBLICATIONS INC. |
| 2025 | Hall, M., Brown, J., Rankin, W., Penno, M., Colman, P., Huynh, D., . . . Couper, J. (2025). Longitudinal changes in exocrine function in early life in children progressing to islet autoimmunity: the ENDIA Study. In HORMONE RESEARCH IN PAEDIATRICS Vol. 98 (pp. 40-41). KARGER. |
| 2024 | Walker, G., Mallitt, K. -A., Sevendal, A., Ward, E., Caguicla, J., Naing, Z., . . . Rawlinson, W. (2024). No increased risk of islet autoimmunity following SARS-CoV-2 infection in ENDIA children. In HORMONE RESEARCH IN PAEDIATRICS Vol. 97 (pp. 198). KARGER. |
| 2023 | Thomson, R. L., Brown, J. D., Oakey, H., Penno, M. A. S., Battersby, R., Ashwood, P., . . . Couper, J. J. (2023). A comparison of lifestyle during pregnancy against Australian recommendations of women with and without type 1 diabetes from the Environmental Determinants of Islet Autoimmunity study. In PROCEEDINGS OF THE NUTRITION SOCIETY Vol. 82 (pp. 1 page). CAMBRIDGE UNIV PRESS. DOI WoS1 |
| 2022 | Haynes, A., Tully, A., Smith, G. J., Penno, M. A. S., Craig, M. E., Wentworth, J. M., . . . Davis, E. A. (2022). Continuous glucose monitoring identifies early dysglycaemia in very young children at risk of type 1 diabetes being followed in the Australian ENDIA pregnancy cohort study. In DIABETOLOGIA Vol. 65 (pp. S173-S174). SWEDEN, Stockholm: SPRINGER. |
| 2019 | Haynes, A., Giles, L., Penno, M., Thomson, R., McGorm, K., Colman, P., . . . ENDIA Study Group. (2019). Cohort profile: the Australia-wide environmental determinants of islet autoimmunity (ENDIA) study. In Diabetologia Vol. 62 (pp. S139-S140). Barcelona, Spain: Springer. |
| 2019 | Begum, M., Pilkington, R. M., Chittleborough, C. R., Lynch, J. W., Penno, M., & Smithers, L. G. (2019). MATERNAL SMOKING DURING PREGNANCY AND RISK OF TYPE 1 DIABETES: WHOLE-OF-POPULATION STUDY. In JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH Vol. 73 (pp. A36-A37). BMJ PUBLISHING GROUP. DOI |
| 2019 | Begum, M., Chittleborough, C. R., Pilkington, R. M., Mittinty, M., Lynch, J. W., Penno, M., & Smithers, L. G. (2019). EDUCATIONAL OUTCOMES AMONG CHILDREN WITH TYPE 1 DIABETES: WHOLE-OF-POPULATION STUDY. In JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH Vol. 73 (pp. A55-A56). BMJ PUBLISHING GROUP. DOI |
| 2018 | Harbison, J. E., Roth-Schulze, A. J., Barry, S. C., Tran, C. D., Ngui, K., Penno, M. A., . . . Couper, J. (2018). Gut Microbiome Dysbiosis and Increased Intestinal Permeability in Australian Children with Islet Autoimmunity and Type 1 Diabetes. In DIABETES Vol. 67 (pp. 2 pages). Orlando, FL: AMER DIABETES ASSOC. DOI WoS2 |
| 2017 | Thomson, R., Penno, M. A., Battersby, R., & Couper, J. (2017). Are pregnant women meeting the Australian dietary guidelines? A comparison of women with and without Type 1 diabetes. In Journal of Nutrition and Intermediary Metabolism Vol. 8 (pp. 76-77). Melbourne: Elsevier. DOI |
| 2017 | Kim, K. W., Allen, D. W., Briese, T., Pang, C. N., Jain, K., Horton, J. L., . . . Craig, M. E. (2017). Gut Virome Dynamics during Pregnancy in Mothers with Type 1 Diabetes. In Abstracts of the 77th Scientific Sessions of the American Diabetes Association, as published in Diabetes Vol. 66 (pp. LB192). San Diego, CA: American Diabetes Association. |
| 2012 | Sciacca, B., François, A., Penno, M., Brazzatti, J., Klingler-Hoffmann, M., Hoffmann, P., & Monro, T. (2012). Radiative-SPR platform for the detection of apolipoprotein E for use in medical diagnostics. In Progress in Biomedical Optics and Imaging - Proceedings of SPIE Vol. 8234 (pp. 1-8). US: SPIE. DOI Scopus1 |
| 2011 | François, A., Courtney, J., Penno, M., Hoffmann, P., & Monro, T. (2011). A novel optical-fiber based surface plasmon resonance sensing architecture and its application to gastric cancer diagnostics. In W. Bock, J. Albert, & X. Bao (Eds.), Proceedings of SPIE Vol. 7753 (pp. 1-4). Ottawa, Canada: SPIE. DOI Scopus3 WoS1 |
| 2008 | Kopetz, V., Penno, M., Hoffmann, P., & Beltrame, J. (2008). Plasma Proteomic Investigations in the Coronary Slow Flow Phenomenon: Exploring Mechanisms for the Acute Coronary Syndrome Presentation. In Heart, Lung and Circulation Vol. 17 (pp. S235). Elsevier BV. DOI |
| Year | Citation |
|---|---|
| 2015 | Hoffmann, P., Penno, M., & Ernst, M. R. W. (2015). BIOMARKERS FOR GASTRIC CANCER AND USES THEREOF. |
Since 2013, Dr Penno has demonstrated sustained success in attracting nationally and internationally competitive research funding to support type 1 diabetes research, cohort infrastructure and translational discovery programs.
As Chief Investigator, associate investigator, and project manager, she has secured and contributed to grants exceeding AU$60 million from major national and international funding bodies.
| Funding Organisation | Application Title (ID) | Amount (AUD) | Funding Application Role | Source | First Funded | Years | Administering Institution |
|---|---|---|---|---|---|---|---|
| Breakthrough T1D | Are there shared mechanisms in naturally acquired and therapeutically induced protection from type 1 diabetes and are they shaped by autoreactive T cell pools and TCR clonality? (2-SRA-2027-2033-M-N) | $1,099,974.50 | Chief Investigator | Domestic | 2026 | 2 | Adelaide University |
| Breakthrough T1D | Designing and delivering optimal care of early type 1 diabetes in Australia (AU arm) (3-SRA-2026-1833-M-N) | $1,605,811 | Chief Investigator | International | 2026 | 3 | Adelaide University |
| Breakthrough T1D Australia | Designing and delivering optimal care of early type 1 diabetes in Australia (US arm) (3-SRA-2026-1949-M-B) | $2,774,154 | Chief Investigator | Domestic | 2026 | 3 | Adelaide University |
| Breakthrough T1D Australia | ENDIA 2026 (201313631) | $2,000,000 | Chief Investigator | Domestic | 2026 | 1 | Adelaide University |
| Channel 7 Children's Research Foundation | Antibody fingerprinting to solve an unsolved crime (50119150) | $99,691 | Chief Investigator | Domestic | 2026 | 1 | Flinders University |
| Medical Research Future Fund | Polygenic Risk-Stratified Population-wide Screening for Type 1 Diabetes in Children (2025/MRF2044979) | $985,164 | Associate investigator | Domestic | 2025 | 2 | University of Sydney |
| Breakthrough T1D | Experiences of children with early-stage T1D and their families (2-SRA-2025-1649-M-B) | $285,000 | Chief Investigator | International | 2025 | 2 | University of Adelaide |
| Breakthrough T1D Australia | The ENDIA 4000 Genomes Project (1-SRA-2025-1703-M-B) | $260,000 | Chief Investigator (first named) | Domestic | 2025 | 1 | University of Adelaide |
| National Health and Medical Research Council (European Union Collaborative Research Grants) | Characterising viruses that promote the development of type 1 diabetes (2023/GNT2032781) | $531,959 | Chief Investigator | Domestic | 2024 | 4 | University of NSW |
| National Institute of Health | High-resolution, virome-wide infection analysis in T1D birth cohorts (R01DK140795-01) | $5,189,862 | Associate Investigator | International | 2024 | 3 | Translational Genomics Research Institute, USA |
| Breakthrough T1D | Using Multi-omics to turn islet autoimmunity driver genes into therapies (3-SRA-2024-1531-S-B) | $599,502 | Chief Investigator | International | 2024 | 3 | University of Adelaide |
| Breakthrough T1D | Investigating the utility of urine C-peptide in early-stage T1D (1-SRA-2024-1582-S-B) | $142,900 | Chief Investigator | International | 2024 | 2 | University of Adelaide |
| Breakthrough T1D | Expanded data mining of accumulated functional genomics data (3-SRA-2024-1532-S-B) | $668,533 | Chief Investigator (first named) | International | 2024 | 3 | University of Adelaide |
| JDRF Australia, JDRF International, and The Leona M. and Harry B. Helmsley Charitable Trust | Deep milk: multi-omics to resolve the role of human breastmilk in T1D risk (2-SRA-2024-1513-M-N) | $795,974 | Chief Investigator | Domestic | 2024 | 2 | Baker Heart and Diabetes Institute |
| JDRF Australia and The Leona M. and Harry B. Helmsley Charitable Trust Partnership | Metabolism in pregnancy and pancreatic beta cell function in offspring (2-SRA-2024-1515-M-N) | $792,694 | Chief Investigator | Domestic | 2024 | 2 | University of Leicester, UK |
| JDRF Australia and The Leona M. and Harry B. Helmsley Charitable Trust Partnership | Establishing immune, endocrine, and exocrine signatures of type 1 diabetes (2-SRA-2024-1514-M-N) | $226,897 | Chief Investigator | Domestic | 2024 | 2 | University of Florida, USA |
| JDRF Australia and The Leona M. and Harry B. Helmsley Charitable Trust Partnership | Familial Sharing of Gut Microbes and Mobile Genetic Elements (2-SRA-2024-1511-M-N) | $401,066 | Chief Investigator | Domestic | 2024 | 2 | University of Helsinki, Finland |
| JDRF Australia and The Leona M. and Harry B. Helmsley Charitable Trust Partnership | Epigenomic Mechanisms of the Maternal Protection in Type 1 Diabetes (2-SRA-2024-1512-M-N) | $799,999 | Chief Investigator | Domestic | 2024 | 2 | University of Colorado, USA |
| Rio Tinto Children's Diabetes Centre Global Centre of Excellence | Investigating the urinary proteome as a source of risk-associated biomarkers (FND005027) | $19,901 | Chief Investigator (first named) | Domestic | 2024 | 1 | University of Adelaide |
| The Leona M. and Harry B. Helmsley Charitable Trust | Immune responses to intestinal bacteria associated with T1D risk and progression (201310593) | $742,072 | Associate investigator | International | 2024 | 2 | Hospital for Sick Kids, Canada |
| The Leona M. and Harry B. Helmsley Charitable Trust | Epigenomic biomarkers of the incomplete maternal protection in type 1 diabetes (244115) | $1,508,166 | Associate investigator | International | 2024 | 1 | University of Colorado, USA |
| National Health and Medical Research Council (Ideas Grants) | Pregnancy and early life virome dynamics: contribution to chronic diseases (2022/GNT2021404) | $1,490,553 | Associate investigator | Domestic | 2023 | 3 | University of NSW |
| Croatian Science Foundation (Hrvatske zaklade za znanost) | Glycosylation of complement component C3 in development of T1D and autoimmunity (IP-2022-10-3983) | $309,285 | Chief Investigator | International | 2023 | 4 | University of Zagreb, Croatia |
| JDRF International | Enhancing risk prediction and stratification through multi-omics profiling (5-CDA-2023-1332-S-B) | $1,428,569 | Chief Investigator | International | 2023 | 5 | University of NSW |
| JDRF Australia | ENDIA Follow Up 2023 - 2025 (3-SRA-2023-1374-M-N) | $8,977,647 | Chief Investigator | Domestic | 2023 | 3 | University of Adelaide |
| The Leona M. and Harry B. Helmsley Charitable Trust | Pancreatic exocrine function and progression to type 1 diabetes in young children (R-2301-06581) | $489,252 | Chief Investigator | International | 2023 | 3 | University of Western Australia |
| National Health and Medical Research Council (Ideas Grants) | A microRNA NanoChip Technology for Predicting Childhood Type 1 Diabetes Risk (2021/GNT2011557) | $399,659 | Chief Investigator | Domestic | 2022 | 2 | University of Western Sydney |
| The Leona M. and Harry B. Helmsley Charitable Trust | CGM Assessments of ENDIA Children (R-2205-05241) | $358,741 | Associate investigator | International | 2022 | 3 | University of Western Australia |
| JDRF Australia | Using 3D genomics to functionally connect genetic risk of T1D to immune genes (2-SRA-2022-1100-M-B) | $565,085 | Chief Investigator | Domestic | 2021 | 2 | University of Adelaide |
| JDRF Australia | Associations between IA risk and plasma proteins, cytokines and lipids (2-SRA-2022-1094-M-B) | $212,063 | Chief Investigator (first named) | Domestic | 2021 | 3 | University of Adelaide |
| The Leona M. and Harry B. Helmsley Charitable Trust | ENDIA Science Continuation (R-2112-04908) | $2,141,466 | Chief Investigator | International | 2021 | 3 | University of Adelaide |
| The Leona M. and Harry B. Helmsley Charitable Trust | ENDIA Expanded Support (R-2103-05117) | $1,428,543 | Chief Investigator (first named) | International | 2021 | 3 | University of Adelaide |
| Diabetes SA | Deep profiling for early biomarkers of progression to IA (FND000388) | $100,000 | Chief Investigator (first named) | Domestic | 2020 | 2 | University of Adelaide |
| JDRF Australia and The Leona M. and Harry B. Helmsley Charitable Trust Partnership | ENDIA 2020-2022 (3-SRA-2020-966-M-N) | $8,253,170 | Chief Investigator | Domestic | 2020 | 3 | University of Adelaide |
| JDRF Australia, JDRF International, and The Leona M. and Harry B. Helmsley Charitable Trust | ENDIA 2019 + supplement (1-SRA-2019-871-M-B) | $4,064,074 | Chief Investigator | Domestic | 2019 | 1 | University of Adelaide |
| Women's and Children's Hospital Foundation | Using CGM to characterise early dysglycaemia in children at risk of T1D (ORG102991) | $75,000 | Chief Investigator (first named) | Domestic | 2019 | 2 | University of Adelaide |
| Australasian Paediatric Endocrine Group | Using CGM to characterise early dysglycaemia in young children at risk of T1D | $15,000 | Associate investigator | Domestic | 2018 | 1 | University of Western Australia |
| Diabetes Research Foundation of WA Inc | Using CGM to characterise early dysglycaemia in young children (FND000927) | $30,000 | Associate investigator | Domestic | 2018 | 1 | University of Western Australia |
| Diabetes SA | The impact of modifiable exposures in the parents and childs environment on T1D risk (FND000388) | $50,000 | Chief Investigator | Domestic | 2018 | 2 | University of Adelaide |
| JDRF International | Testing the potential of human gut microbiota to prevent T1D in the NOD mouse (2-SRA-2019-731-S-B) | $220,602 | Chief Investigator | International | 2018 | 2 | University of Queensland |
| JDRF International | Maternal-infant microbiomes that precede the onset of islet autoimmunity (1-SRA-2018-543-S-B) | $321,481 | Chief Investigator | International | 2017 | 1 | Walter and Eliza Hall Institute |
| University of Adelaide Robinson Research Institute | Robinson Research Institute Engaging Opportunities Program | $25,000 | Associate investigator | Domestic | 2016 | 1 | University of Adelaide |
| JDRF Australia, and The Leona M. and Harry B. Helmsley Charitable Trust Partnership | ENDIA 2015-2018 (4-SRA-2015-127-M-B) | $8,006,375 | Project leader/manager | Domestic | 2015 | 4 | University of Adelaide |
| University of Adelaide Robinson Research Institute | Strike a Cord: the development and implementation of a RRI umbilical cord blood and placental tissue | $10,000 | Chief Investigator (first named) | Domestic | 2015 | 2 | University of Adelaide |
| National Health and Medical Research Council (Centre of Research Excellence) | Centre of Research Excellence for the Protection of Pancretic Beta Cells (APP1078106) | $2,500,000 | Project leader/manager | Domestic | 2014 | 5 | University of Adelaide |
| University of Adelaide Robinson Research Institute | Capacity Building in Bioinformatics and Biostatistics Funding Program | $18,000 | Chief Investigator (first named) | Domestic | 2013 | 1 | University of Adelaide |
Dr Penno’s teaching and supervisory contributions encompass Higher Degree by Research (HDR) supervision, research training, mentorship and leadership in research capacity building across the type 1 diabetes research community.
Dr Penno currently co-supervises two PhD candidates at the University of Adelaide and the University of Queensland, investigating the role of the exocrine pancreas and gut microbiota in type 1 diabetes progression. To strengthen researcher development across institutions, she established and convenes the ENDIA HDR Student Group, which supports training, collaboration and peer development among 12 HDR candidates from universities across Australia.
Beyond formal supervision, Dr Penno has played a significant role in mentoring PhD candidates, honours students, postdoctoral researchers and early-career investigators working within ENDIA and related national research programs. Through this mentorship, she has supported the development of research careers that have resulted in publications, fellowship success, national and international collaborations, and increasing research independence. She has also contributed to candidature and milestone reviews, honours thesis assessment, and postgraduate teaching through the University of Adelaide's Biology of Childhood Growth, Development and Health course.
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2025 | Co-Supervisor | The Exocrine Pancreas in the Progression to Type 1 Diabetes | Doctor of Philosophy | Doctorate | Full Time | Miss Madeleine Victoria Hall |
| Date | Role | Research Topic | Location | Program | Supervision Type | Student Load | Student Name |
|---|---|---|---|---|---|---|---|
| 2025 - ongoing | Co-Supervisor | Function of the gut microbiota during progression of T1D | University of Adelaide | University of Queensland | Doctorate | Full Time | Mehran Radak |
| Date | Topic | Location | Name |
|---|---|---|---|
| 2025 - ongoing | ENDIA HDR Student Group Convenor | University of Adelaide | ENDIA HDR Students |
| 2015 - ongoing | Specimen collection for pancreatic volume study | Women's and Children's Hospital | Priya Augustine |
| 2013 - ongoing | Microbiome studies involving the TIGS cohort | University of Adelaide | Jessica Harbison |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2026 - ongoing | Member | College of Health Low Risk Ethics Committee | Adelaide University | Australia |
| 2025 - ongoing | Member | Faculty of Health and Medical Sciences Lower Risk Human Research Ethics Committee | University of Adelaide | Australia |
| 2024 - 2026 | Member | Immunology of Diabetes Society 2026 Congress Scientific Program Committee | Immunology of Diabetes Society | United States |
| 2024 - ongoing | Member | Breakthrough T1D T1DCRN Functional Genomics Interest Group | Breakthrough T1D Australia | Australia |
| 2024 - 2025 | Member | JDRF Global Centre of Excellence Talent & Capacity Building Subcommittee | Telethon Kids Institute | Australia |
| 2023 - 2026 | Member | Immunology of Diabetes Society 2026 Congress Local Organising Committee | Immunology of Diabetes Society | Australia |
| 2021 - ongoing | Member | South Australian Biobanking Technical Reference Group | The University of Adelaide | Australia |
| 2020 - 2020 | Member | New Women’s and Children’s Hospital Project User Groups: University Research Space, Library & Education Training Spaces, Research Secretariat | Women's and Children's Hospital | Australia |
| 2019 - ongoing | Member | Research Freezer Management Policy Working Group | The University of Adelaide | Australia |
| 2018 - 2019 | Member | DOHaD World Congress Symposium Sub-Committee | DOHaD Society | Australia |
| 2016 - ongoing | Member | Health Consumer Engagement Executive Subcommittee | University of Adelaide, Robinson Research Institute | Australia |
| 2016 - 2016 | Member | RRI 2016 Symposium Organising Committee | University of Adelaide, Robinson Research Institute | Australia |
| 2016 - ongoing | Founder | RRI Early/Mid Career Researcher Committee | University of Adelaide, Robinson Research Institute | Australia |
| 2016 - ongoing | Chair | ENDIA Steering Committee | ENDIA Study Group | Australia |
| 2016 - ongoing | Member | ENDIA Steering Committee Executive | The ENDIA Study | Australia |
| 2015 - ongoing | Member | The High Performance Researcher Group | ThinkWell | Australia |
| 2014 - 2015 | Member | Adelaide Family Health Study Protocol Development Working Group | The University of Adelaide, Robinson Research Institute | Australia |
| 2014 - ongoing | Founder | Robinson Research Institute Study Coordinator Network Advisory Committee | The University of Adelaide, Robinson Research Institute | Australia |
| 2013 - ongoing | Member | Robinson Research Institute CIS Facility Steering Group | University of Adelaide, Robinson Research Institute | Australia |
| 2013 - ongoing | Member | JDRF International Microbiome Consortium | JDRF International | Australia |
| 2007 - 2009 | Member | Adelaide Protein Group | Australian Society for Biochemistry and Molecular Biology | Australia |
| Date | Title | Type | Institution | Country |
|---|---|---|---|---|
| 2026 - 2026 | Breakthrough T1D FY26 SRA Project Concept Review Panel | Grant Assessment | Breakthrough T1D | United States |
| 2025 - 2025 | Breakthrough T1D Fellowships Review Panel | Grant Assessment | Breakthrough T1D | Australia |
| 2025 - 2025 | Breakthrough T1D International Training Award Review Panel | Grant Assessment | Breakthrough T1D International | United States |
